BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9831899)

  • 1. Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes.
    Wettwer E; Himmel HM; Amos GJ; Li Q; Metzger F; Ravens U
    Br J Pharmacol; 1998 Oct; 125(4):659-66. PubMed ID: 9831899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID; Cleemann L; Morad M
    J Pharmacol Exp Ther; 1990 Aug; 254(2):560-9. PubMed ID: 2384886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different inhibition patterns of tedisamil for fast and slowly inactivating transient outward current in rat ventricular myocytes.
    Berger F; Borchard U; Hafner D; Weis TM
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):291-8. PubMed ID: 9550301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tedisamil inactivates transient outward K+ current in rat ventricular myocytes.
    Dukes ID; Morad M
    Am J Physiol; 1989 Nov; 257(5 Pt 2):H1746-9. PubMed ID: 2556052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the antifibrillatory compound tedisamil (KC-8857) on transmembrane currents in mammalian ventricular myocytes.
    Jost N; Virág L; Hála O; Varró A; Thormählen D; Papp JG
    Curr Med Chem; 2004 Dec; 11(24):3219-28. PubMed ID: 15579009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed blockade of K+ and Na+ currents in rat ventricular myocytes by the tedisamil analogue, KC8851.
    McLarnon JG; Xu R
    Eur J Pharmacol; 1997 Nov; 339(2-3):279-88. PubMed ID: 9473146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers.
    Németh M; Virág L; Hála O; Varró A; Kovács G; Thormählen D; Papp JG
    Cardiovasc Res; 1996 Feb; 31(2):246-8. PubMed ID: 8730401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito.
    Radicke S; Cotella D; Sblattero D; Ravens U; Santoro C; Wettwer E
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jun; 379(6):617-26. PubMed ID: 19153714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of glibenclamide, tedisamil, dofetilide, E-4031, and BRL-32872 on protein kinase A-activated chloride current in guinea pig ventricular myocytes.
    Faivre JF; Rouanet S; Bril A
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):551-7. PubMed ID: 9554804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tedisamil blocks BK-type Ca(2+)-dependent K(+) channels and modulates action potentials in rat hippocampal neurons.
    Church J; McLarnon JG
    Neurosci Lett; 2002 Feb; 319(2):79-82. PubMed ID: 11825675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of transient outward K(+) channel block by disopyramide.
    Sanchez-Chapula JA
    J Pharmacol Exp Ther; 1999 Aug; 290(2):515-23. PubMed ID: 10411557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open channel block of the fast transient outward K+ current by primaquine and chloroquine in rat left ventricular cardiomyocytes.
    Wagner M; Riepe KG; Eberhardt E; Volk T
    Eur J Pharmacol; 2010 Nov; 647(1-3):13-20. PubMed ID: 20807529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of E-4031, almokalant and tedisamil on postrest action potential duration of human papillary muscles.
    Ohler A; Ravens U
    J Pharmacol Exp Ther; 1994 Aug; 270(2):460-5. PubMed ID: 7520940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tedisamil: master switch of nature?
    Doggrell SA
    Expert Opin Investig Drugs; 2001 Jan; 10(1):129-38. PubMed ID: 11116286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of antiarrhythmic agent bertosamil on hKv1.5 channels and outward potassium current in human atrial myocytes.
    Godreau D; Vranckx R; Hatem SN
    J Pharmacol Exp Ther; 2002 Feb; 300(2):612-20. PubMed ID: 11805224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN; Abraham S; MacLeod BA; Yoshida NR; Walker MJ
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tedisamil blocks a calcium-dependent potassium channel in cultured motoneurons.
    McLarnon JG; Sawyer D; Michikawa M; Kim SU
    Neurosci Lett; 1992 Sep; 144(1-2):185-8. PubMed ID: 1436700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ajmaline on transient outward current in rat ventricular myocytes.
    Bébarová M; Matejovic P; Pásek M; Simurdová M; Simurda J
    Gen Physiol Biophys; 2005 Mar; 24(1):27-45. PubMed ID: 15900085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.